2025/10/23
Shandong Xinbo Assists Ningbo Aixoso in Obtaining Clinical Approval for Innovative Endometriosis Drug
According to the official website of the Center for Drug Evaluation (CDE) of the National Medical Products Administration and public information, Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") has assisted Ningbo Aikoso Pharmaceutical Technology Co., Ltd. in developing the "EGFNASA Capsule" (acceptance number: CXHL2500729), which has obtained implied permission for clinical trials of new drugs ......
